Is glutathione (glutathione) safe for a breastfeeding mother, particularly one with a pre-existing condition like diabetes (diabetes mellitus)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Glutathione and Breastfeeding Safety

Glutathione supplementation during breastfeeding lacks safety data and is not recommended, particularly for mothers with diabetes who should focus on evidence-based diabetes management strategies that are proven safe during lactation.

Key Safety Considerations

The evidence does not address glutathione supplementation specifically during breastfeeding. However, the general principle for lactation is clear:

  • Breastfeeding is strongly recommended for all women with diabetes, including those with pre-existing type 1, type 2, or gestational diabetes, due to substantial metabolic benefits for both mother and infant 1.
  • Breastfeeding reduces the risk of developing type 2 diabetes in mothers with previous gestational diabetes (OR 0.68 [95% CI 0.57-0.82]) 1.
  • For infants, breastfeeding reduces infant mortality from infectious diseases (OR 0.22-0.59), respiratory infections, and asthma risk (OR 0.91 [0.85-0.98]) 1.

Evidence-Based Diabetes Management During Lactation

Instead of unproven supplements like glutathione, use these established safe options:

First-Line Treatment

  • Insulin remains the gold standard for diabetes management during breastfeeding and is completely safe 2, 3, 4.
  • Lactating women typically require substantially less insulin (approximately 34% lower than prepregnancy requirements initially) due to calories expended with nursing 1, 2.

Oral Agents (If Needed)

  • Metformin is excreted into breast milk but does not appear to cause harmful neonatal effects in available studies, though it is generally preferred as a safe option 2, 3.
  • Second-generation sulfonylureas (glyburide or glipizide) can be safely used by breastfeeding women 2, 3.
  • The American Academy of Pediatrics recommends tolbutamide as the preferred oral hypoglycemic during breastfeeding, though the infant should be monitored for jaundice 4.

Important Cautions

  • Newer diabetes agents require extreme caution because they have not been studied in lactation 3.
  • GLP-1 receptor agonists like semaglutide should be avoided during breastfeeding according to American College of Cardiology guidelines 2.

Practical Management for Breastfeeding Mothers with Diabetes

Hypoglycemia Prevention

  • Breastfeeding lowers blood glucose, often requiring a carbohydrate-containing snack before or during nursing 1, 2.
  • Evening or late-night snacks may be necessary to prevent accelerated ketosis overnight 1.
  • Lactation increases the risk of overnight hypoglycemia, requiring insulin dose adjustments 1.

Nutritional Requirements

  • Adequate energy intake is critical to prevent ketosis during lactation 1.
  • Energy requirements during the first 6 months of lactation require an additional 200 calories above the pregnancy meal plan 1.
  • An energy intake of 1,800 kcal/day usually meets nutritional requirements for lactation and may allow slow weight loss of 1-2 lb/month 1.
  • Lactation requires approximately 500 additional calories per day 2.

Monitoring Considerations

  • Monitor for ketones in the mother because acetone is excreted in breast milk and may adversely affect the infant's liver 4.
  • Use glucose-specific monitoring methods, as lacturia may interfere with nonspecific urine glucose measurements 4.

Why Avoid Unproven Supplements

Herbal supplements and unproven agents are concerning due to risk of impurities and lack of study of effects on breastfed infants 3. Glutathione falls into this category—while breast milk naturally contains glutathione (192.2 ± 148.3 μmol/L), with higher levels in early milk 5, there is no evidence supporting maternal supplementation during lactation, and the safety profile is unknown.

Common Pitfalls to Avoid

  • Do not assume that "natural" supplements are automatically safe during breastfeeding—they lack the rigorous safety testing of approved medications 3.
  • Do not discontinue breastfeeding due to diabetes—the metabolic benefits far outweigh the management challenges 1.
  • Do not forget to adjust insulin doses immediately postpartum, as insulin sensitivity increases dramatically with placental delivery 1.
  • Women with gestational diabetes have higher rates of formula supplementation despite intending to exclusively breastfeed, often citing "medical reasons"—provide extra lactation support to this population 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Breastfeeding Considerations with Semaglutide

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Medication Safety in Breastfeeding.

American family physician, 2022

Research

Antidiabetic agents and lactation.

Journal of human lactation : official journal of International Lactation Consultant Association, 1992

Research

Human breastmilk storage and the glutathione content.

Journal of tropical pediatrics, 2000

Related Questions

What is the management of hyperglycemia (high blood sugar) in lactating mothers?
What diabetic oral medications, such as metformin (Metformin), are safe for breastfeeding mothers?
What is the recommended treatment for acute pharyngitis in breastfeeding mothers?
What type of medication is preferred for use during breastfeeding to reduce the risk of harm to the infant, considering characteristics such as oral bioavailability and protein binding?
Is it safe for a breastfeeding mom to take Althea (Marshmallow root) pills?
What muscle spasm medication is recommended for an elderly patient with a history of metabolic encephalopathy and opioid dependence?
What is the recommended dosing and monitoring strategy for a patient with type 2 diabetes (T2D) and potential comorbidities, such as cardiovascular disease or neuropathy, when initiating Neutral Protamine Hagedorn (NPH) insulin therapy?
What causes severe postpartum depression (PPD) in a postpartum female, possibly with a history of mental health issues or previous experiences with PPD?
What is the most effective insulin therapy for a patient with type 2 diabetes (T2D) and comorbidities such as cardiovascular disease (CVD) or neuropathy, considering head-to-head trials for insulin in T2D?
Do patients new to pregabalin (lyrica), with normal renal function, average weight, and no significant comorbidities, experience any therapeutic effects from a starting dose of 25 milligrams?
What is the next step in management for a postmenopausal (post-hysterectomy) female patient with fever, no specific complaints, and a clean wound?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.